Cargando…

Substance use and HIV stage at entry into care among people with HIV

ABSTRACT: BACKGROUND: Information regarding the impact of substance use on the timing of entry into HIV care is lacking. Better understanding of this relationship can help guide approaches and policies to improve HIV testing and linkage. METHODS: We examined the effect of specific substances on stag...

Descripción completa

Detalles Bibliográficos
Autores principales: Parrish, Canada, Whitney, Bridget M., Nance, Robin M., Puttkammer, Nancy, Fishman, Paul, Christopoulos, Katerina, Fleming, Julia, Heath, Sonya, Mathews, William Christopher, Chander, Geetanjali, Moore, Richard D., Napravnik, Sonia, Webel, Allison, Delaney, Joseph, Crane, Heidi M., Kitahata, Mari M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8401238/
https://www.ncbi.nlm.nih.gov/pubmed/34454630
http://dx.doi.org/10.1186/s13690-021-00677-2
Descripción
Sumario:ABSTRACT: BACKGROUND: Information regarding the impact of substance use on the timing of entry into HIV care is lacking. Better understanding of this relationship can help guide approaches and policies to improve HIV testing and linkage. METHODS: We examined the effect of specific substances on stage of HIV disease at entry into care in over 5000 persons with HIV (PWH) newly enrolling in care. Substance use was obtained from the AUDIT-C and ASSIST instruments. We examined the association between early entry into care and substance use (high-risk alcohol, methamphetamine, cocaine/crack, illicit opioids, marijuana) using logistic and relative risk regression models adjusting for demographic factors, mental health symptoms and diagnoses, and clinical site. RESULTS: We found that current methamphetamine use, past and current cocaine and marijuana use was associated with earlier entry into care compared with individuals who reported no use of these substances. CONCLUSION: Early entry into care among those with substance use suggests that HIV testing may be differentially offered to people with known HIV risk factors, and that individuals with substances use disorders may be more likely to be tested and linked to care due to increased interactions with the healthcare system.